UCB's Neupro hits US market again
This article was originally published in Scrip
Executive Summary
UCB has again launched its once daily rotigotine patch Neupro in the US for patients with the signs and symptoms of idiopathic Parkinson's disease and moderate to severe primary Restless Legs Syndrome. First launched in the US in 2007, the firm voluntarily recalled the drug there the following year.